BMD's (BioMedical Diagnostics) automated sample preparation tech:
This article was originally published in Clinica
Executive Summary
French firm BMD (BioMedical Diagnostics) has CE-marked for sale in Europe an automated module for preparing test samples for autoimmune disease diagnosis. Called Caris (carrier for assay reagents and immuno samples), the module has been incorporated into the firm's high throughput diagnostic system, Fidis FPX. Caris fully automates the preparation process including sample identification, dilution, dispensing and wash steps. Users merely insert the reaction plate into the Fidis system to begin high throughput analysis of the samples, said the Marne-la-Vallee, greater Paris firm.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.